EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO

Patricia Willisch, Elena Villafranca, Susana Roldan Ortega, Silvia Rodriguez Villalba, Alai Goñi, Juan Adrian Camus, Luis Sopeña Sanz, Ana Alonso García, Teresa Muñoz Miguelañez, Saul Lopez-Soliño, Beatriz Vázquez-Barreiro, David Büchser

Brachytherapy · 2026

DOI: 10.1016/j.brachy.2025.09.014 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brachytherapy, 2026. Verfasst von Patricia Willisch und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Meixoeiro Hospital, Vigo, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Salvage Therapy, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate oncologic outcomes, prognostic factors, and toxicity associated with salvage brachytherapy in locally recurrent prostate cancer after radiotherapy and assess the role of next-generation imaging in early detection. METHODS: A retrospective, multicenter cohort study was conducted including 188 patients treated with salvage HDR or LDR brachytherapy, with or without androgen deprivation therapy (ADT), across 10 Spanish centers. Primary endpoints were biochemical relapse-free survival (bRFS), clinical relapse-free survival (CRFS), and overall survival (OS). Survival probabilities were estimated using the Kaplan-Meier method, and predictive factors assessed using Cox proportional hazards models. RESULTS: With a median follow-up of 64.6 months, 5- and 10-year bRFS were 64.9% and 61.7%, and CRFS were 72.3% and 68.1%, respectively. OS at 5 and 10 years was 97.9% and 93.6%. Time to PSA nadir and lower nadir values were associated with improved bRFS and CRFS. Gleason score >7 and higher PSA at recurrence predicted worse outcomes. Next-generation imaging enhanced early detection. BED >216 Gy improved control but raised urinary toxicity. Grade 3 acute and late urinary toxicity rates were 2.8% and 3.1%, respectively. CONCLUSIONS: Salvage brachytherapy is an effective option for locally recurrent prostate cancer. PSA dynamics and advanced imaging improve patient selection. BED optimization remains critical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapySalvage TherapyNeoplasm Recurrence, LocalHumansMaleRetrospective StudiesAgedMiddle AgedDose Fractionation, RadiationSurvival RateTreatment OutcomeAged, 80 and overSpainDisease-Free Survival

Stichwörter der Autor:innen

BrachytherapyNew generation imageProstate cancer local recurrenceRe-irradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Meixoeiro Hospital, Vigo, Spain.
  • Department of Radiation Oncology, Navarra University Hospital, Pamplona, Spain.
  • Department of Radiation Oncology, La Fe University Hospital, Valencia, Spain.
  • Department of Radiation Oncology, Benidorm Hospital, Benidorm, Spain.
  • Department of Radiation Oncology, Oncologikoa Foundation, Donostia, Spain.
  • Department of Radiation Oncology, Reina Sofía University Hospital, Córdoba, Spain.

Zitieren

APA

Willisch, P., Villafranca, E., Roldan Ortega, S., Rodriguez Villalba, S., Goñi, A., Camus, J. A., Sopeña Sanz, L., Alonso García, A., Muñoz Miguelañez, T., Lopez-Soliño, S., Vázquez-Barreiro, B., & Büchser, D. (2026). Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.09.014

Vancouver

Willisch P, Villafranca E, Roldan Ortega S, Rodriguez Villalba S, Goñi A, Camus JA, et al. Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO. Brachytherapy. 2026. doi:10.1016/j.brachy.2025.09.014

BibTeX
@article{Willisch2026,
  author = {Willisch, Patricia and Villafranca, Elena and Roldan Ortega, Susana and Rodriguez Villalba, Silvia and Goñi, Alai and Camus, Juan Adrian and Sopeña Sanz, Luis and Alonso García, Ana and Muñoz Miguelañez, Teresa and Lopez-Soliño, Saul and Vázquez-Barreiro, Beatriz and Büchser, David},
  title = {Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO},
  journal = {Brachytherapy},
  year = {2026},
  doi = {10.1016/j.brachy.2025.09.014}
}
Kostenlos starten →